Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

81.

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.

Lancet.
Leder BZ, Tsai JN, Uihlein AV, Wallace PM, Lee H, Neer RM, Burnett-Bowie SA.
| Sep 19, 2015
82.

ReEBOV Antigen Rapid Test kit for point-of-care and laboratory-based testing for Ebola virus disease: a field validation study.

Lancet.
Broadhurst MJ, Kelly JD, Miller A, Semper A, Bailey D, Groppelli E, Simpson A, Brooks T, Hula S, Nyoni W, Sankoh AB, Kanu S, Jalloh A, Ton Q, Sarchet N, George P, Perkins MD, Wonderly B, Murray M, Pollock NR.
| Aug 29, 2015
83.

Current concepts in management of pain in children in the emergency department.

Lancet.
Krauss BS, Calligaris L, Green SM, Barbi E.
| Jan 2, 2016
84.

Dual antiplatelet therapy duration and mortality - Authors' reply.

Lancet.
Yeh RW, Elmariah S, Doros G, Kereiakes DJ, Mauri L.
| May 30, 2015
85.

African health leaders: claiming the future.

Lancet.
Binagwaho A, Crisp N.
| May 30, 2015
86.

Women and Health: the key for sustainable development.

Lancet.
Langer A, Meleis A, Knaul FM, Atun R, Aran M, Arreola-Ornelas H, Bhutta ZA, Binagwaho A, Bonita R, Caglia JM, Claeson M, Davies J, Donnay FA, Gausman JM, Glickman C, Kearns AD, Kendall T, Lozano R, Seboni N, Sen G, Sindhu S, Temin M, Frenk J.
| Sep 19, 2015
87.

Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial.

Lancet.
Long GV, Stroyakovskiy D, Gogas H, Levchenko E, de Braud F, Larkin J, Garbe C, Jouary T, Hauschild A, Grob JJ, Chiarion-Sileni V, Lebbe C, Mandalà M, Millward M, Arance A, Bondarenko I, Haanen JB, Hansson J, Utikal J, Ferraresi V, Kovalenko N, Mohr P, Probachai V, Schadendorf D, Nathan P, Robert C, Ribas A, DeMarini DJ, Irani JG, Swann S, Legos JJ, Jin F, Mookerjee B, Flaherty K.
| Aug 1, 2015
88.

Global health security: the wider lessons from the west African Ebola virus disease epidemic.

Lancet.
Heymann DL, Chen L, Takemi K, Fidler DP, Tappero JW, Thomas MJ, Kenyon TA, Frieden TR, Yach D, Nishtar S, Kalache A, Olliaro PL, Horby P, Torreele E, Gostin LO, Ndomondo-Sigonda M, Carpenter D, Rushton S, Lillywhite L, Devkota B, Koser K, Yates R, Dhillon RS, Rannan-Eliya RP.
| May 9, 2015
89.

50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study.

Lancet.
Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D.
| Jul 11, 2015
90.

An active shooter in our hospital.

Lancet.
Goralnick E, Walls R.
| May 2, 2015
91.

Risk factors for and origins of COPD.

Lancet.
Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB.
| May 2, 2015
92.

Reducing the burden of iatrogenic harm in children.

Lancet.
Carson-Stevens A, Edwards A, Panesar S, Parry G, Rees P, Sheikh A, Donaldson L.
| Apr 25, 2015
93.

The history and fate of the gold standard.

Lancet.
Jones DS, Podolsky SH.
| Apr 18, 2015
94.

Surgical palliative care in resource-limited settings.

Lancet.
Riesel JN, Mandigo M, Gillies R, Damuse R, Farmer PE, Cusack JC, Krakauer EL, Shulman LN.
| Aug 8, 2015
95.

Global surgery--going beyond the Lancet Commission.

Lancet.
Davies JI, Meara JG.
| Aug 8, 2015
96.

Global Surgery 2030: evidence and solutions for achieving health, welfare, and economic development.

Lancet.
Meara JG, Leather AJ, Hagander L, Alkire BC, Alonso N, Ameh EA, Bickler SW, Conteh L, Dare AJ, Davies J, Mérisier ED, El-Halabi S, Farmer PE, Gawande A, Gillies R, Greenberg SL, Grimes CE, Gruen RL, Ismail EA, Kamara TB, Lavy C, Lundeg G, Mkandawire NC, Raykar NP, Riesel JN, Rodas E, Rose J, Roy N, Shrime MG, Sullivan R, Verguet S, Watters D, Weiser TG, Wilson IH, Yamey G, Yip W.
| Aug 8, 2015
97.

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.

Lancet.
Sax PE, Wohl D, Yin MT, Post F, DeJesus E, Saag M, Pozniak A, Thompson M, Podzamczer D, Molina JM, Oka S, Koenig E, Trottier B, Andrade-Villanueva J, Crofoot G, Custodio JM, Plummer A, Zhong L, Cao H, Martin H, Callebaut C, Cheng AK, Fordyce MW, McCallister S, Achenbach C.
| Jun 27, 2015
98.

On the (f)utility of pain.

Lancet.
Stonington SD.
| Apr 11, 2015
99.

Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial.

Lancet.
Ardehali A, Esmailian F, Deng M, Soltesz E, Hsich E, Naka Y, Mancini D, Camacho M, Zucker M, Leprince P, Padera R, Kobashigawa J, Baran D.
| Jun 27, 2015
100.

Diagnosis of reversible causes of coma - Authors' reply.

Lancet.
Edlow JA, Rabinstein A, Traub SJ, Wijdicks EF.
| Mar 28, 2015